Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ISTH0047 |
Synonyms | |
Therapy Description |
ISTH0047 is a locked nucleic acid antisense oligonucleotide that targets TGF-beta2, which may result in decreased stromal TGF-beta2 expression and reduced tumor metastasis (PMID: 28911087, PMID: 31530630). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ISTH0047 | ISTH-0047|ISTH 0047 | Antisense Therapy 13 | ISTH0047 is a locked nucleic acid antisense oligonucleotide that targets TGF-beta2, which may result in decreased stromal TGF-beta2 expression and reduced tumor metastasis (PMID: 28911087, PMID: 31530630). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|